Key points are not available for this paper at this time.
Chimeric antigen receptor T-cell (CAR-T) therapy has significantly improved survival for adult patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL). However, there are novel toxicitie...
Major et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: